Wolfe Research analyst Chris Caso notes ASML posted solid Q2 bookings and maintained full year 2024 guidance, which the firm thinks sets up for a strong second half of 2024 and 2025. The stock is, however, down on the report, which Wolfe attributes to two reasons. One concern relates to Q3 revenue guide coming in slightly below consensus, but the firm thinks that’s simply a function of timing. The other relates to reports of additional pressure from the U.S. government regarding China restrictions. According to news reports, Washington is seeking to restrict service on restricted tools, for which U.S. companies are already restricted but ASML is not. Wolfe notes Washington is seeking leverage via the foreign direct product rule. But its initial interpretation is that the goal is to restrict service, not to further restrict older immersion tools. If the firm’s interpretation is correct, this too would represent noise, since China services are a small part of revenue. Wolfe’s first reaction is to buy ASML on the pullback. The firm has an Outperform rating on the shares with a price target of EUR 1,050.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASML:
- ASML Earnings: ASML Nosedives as Macro Concerns Overshadow Q2 Results
- Options Volatility and Implied Earnings Moves Today, July 17, 2024
- ASML reports €6.2 billion total net sales and €1.6 billion net income in Q2 2024
- Options Volatility and Implied Earnings Moves This Week, July 15 – July 19, 2024
- Asml Holding N.V. (ASML) Q2 Earnings Cheat Sheet